Cargando…

Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment

BACKGROUND: Coronavirus disease 2019 (COVID-19) pandemic affected millions of individuals, and patients with cancer are known to be more susceptible. Vaccines against SARS-CoV-2 have been developed and used for patients with cancer, but scarce data are available on their efficacy in patients under a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jinyong, Chang, Euijin, Park, Song Yi, Lee, Dae-Won, Kang, Chang Kyung, Choe, Pyoeng Gyun, Kim, Nam Joong, Oh, Myoung-don, Park, Wan Beom, Lee, Kyung-Hun, Im, Seock-Ah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732225/ https://www.ncbi.nlm.nih.gov/pubmed/36218350 http://dx.doi.org/10.1093/oncolo/oyac196

Ejemplares similares

Clinical Impact of Empirical Antibiotic Therapy in Patients With Coronavirus Disease 2019 Requiring Oxygen Therapy
por: Park, Do Hyeon, et al.
Publicado: (2022)

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
por: Kim, Jinyong, et al.
Publicado: (2022)

A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients
por: Park, Do Hyeon, et al.
Publicado: (2021)

Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
por: Choe, Pyoeng Gyun, et al.
Publicado: (2022)

Work Restrictions for Healthcare Personnel with Potential In-hospital Exposure to SARS-CoV-2: Experience at a Tertiary Hospital
por: Jo, Hyeon Jae, et al.
Publicado: (2021)

Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection
por: Oh, Sang-Min, et al.
Publicado: (2021)

How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea
por: Park, Do Hyeon, et al.
Publicado: (2022)

416. Poor clinical outcomes of COVID-19 patients receiving rituximab during the Omicron era
por: Lee, Chan Mi, et al.
Publicado: (2023)

Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies
por: Park, Jae Hyeon, et al.
Publicado: (2023)

Prolonged (6-Month) Shedding of Middle East Respiratory Syndrome Coronavirus RNA in the Sputum of a Lymphoma Patient
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

Limited Positive Predictive Value of β-d-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
por: Chang, Euijin, et al.
Publicado: (2020)

A cluster of tertiary transmissions of 2019 novel coronavirus (SARS-CoV-2) in the community from infectors with common cold symptoms
por: Kim, Nam Joong, et al.
Publicado: (2020)

Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii
por: Bae, Ji Yun, et al.
Publicado: (2018)

Pentoxifylline and vitamin E drug compliance after adjuvant breast radiation therapy
por: Famoso, Justin M., et al.
Publicado: (2017)

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Narrowing Racial Gaps in Breast Cancer: Factors Affecting Probability of Adjuvant Radiation Therapy
por: Snead, Felicia, et al.
Publicado: (2019)

Impact of Adjuvant Radiation Therapy in Patients With Male Breast Cancer: A Multicenter International Analysis
por: Rolf, Daniel, et al.
Publicado: (2020)

Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population‐Based Cohort Study
por: Franchi, Matteo, et al.
Publicado: (2020)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

Incidence of invasive fungal infection in acute lymphoblastic and acute myelogenous leukemia in the era of antimold prophylaxis
por: Oh, Sang-Min, et al.
Publicado: (2021)

Hormone Receptor Subtype in Ductal Carcinoma in Situ: Prognostic and Predictive Roles of the Progesterone Receptor
por: Hwang, Ki‐Tae, et al.
Publicado: (2021)

Talazoparib in Patients with a Germline BRCA‐Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial
por: Hurvitz, Sara A., et al.
Publicado: (2019)

Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program
por: Le Du, Fanny, et al.
Publicado: (2023)

A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance
por: Ahn, Byeong Yun, et al.
Publicado: (2020)

Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Antibody Responses One Year after Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
por: Kang, Chang Kyung, et al.
Publicado: (2020)

Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
por: Lee, Chan Mi, et al.
Publicado: (2023)

813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit
por: Jung, Jongtak, et al.
Publicado: (2020)

Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS‐441524 in patients with COVID‐19: A limited case series
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Comparison of the Diagnostic Performance of Response Evaluation Criteria in Solid Tumor 1.0 with Response Evaluation Criteria in Solid Tumor 1.1 on MRI in Advanced Breast Cancer Response Evaluation to Neoadjuvant Chemotherapy
por: Jeh, Su Kyung, et al.
Publicado: (2013)

In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus
por: Lee, Myung Jin, et al.
Publicado: (2017)

A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial
por: Blackwell, Kimberly, et al.
Publicado: (2016)

A Workhorse Flap for Covering Moderate-sized Defects after Breast-conserving Surgery: Supercharged Lateral Thoracodorsal Flap
por: Kim, Do Gon, et al.
Publicado: (2021)

Sonography of Invasive Apocrine Carcinoma of the Breast in Five Cases
por: Seo, Kyung-Jin, et al.
Publicado: (2015)

Selecting coronavirus disease 2019 patients with negligible risk of progression: early experience from non-hospital isolation facility in Korea
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

Changes in Anxiety Level and Personal Protective Equipment Use Among Healthcare Workers Exposed to COVID-19
por: Park, Do Hyeon, et al.
Publicado: (2022)

Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea
por: Kang, Chang Kyung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ki2otbgvokuej4n7iams4lt2eo